Checkmate Pharmaceuticals

$13.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.11%) As of 4:38 PM UTC today

Why Robinhood?

You can buy or sell CMPI and other stocks, options, and ETFs commission-free!

About CMPI

Checkmate Pharmaceuticals, Inc. Common Stock, also called Checkmate Pharmaceuticals, is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. The listed name for CMPI is Checkmate Pharmaceuticals, Inc. Common Stock.

CEO
Barry A. Labinger
Employees
22
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
312.58M
Price-Earnings Ratio
Dividend Yield
Average Volume
24.51K
High Today
$13.71
Low Today
$13.36
Open Price
$13.57
Volume
4.22K
52 Week High
$23.10
52 Week Low
$8.61

CMPI Earnings

-$7.37
-$4.91
-$2.46
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 30, Pre-Market

You May Also Like

ACGBY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure